Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Jan 29;21(4):589–603. doi: 10.1016/j.bbmt.2014.12.031

Table 2.

Recommendation for Final Diagnosis Categories

Category Definition Examples Comments
Not GVHD No evidence for GVHD
Possible GVHD Evidence of GVHD but other possible explanations
  • Obvious CMV enteritis with inclusions near the apoptotic changes

  • Focal colonic ulcers with marked apoptotic cryptitis and destruction of crypts associated with use of MMF

  • Co-infection with known active viral hepatitis

  • Clinical features which suggest or favor a drug reaction

Indicate possible alternate diagnoses and reasons for suspicion
Likely GVHD Clear evidence of GVHD without a competing cause of injury
OR
Clear evidence of GVHD with mitigating factors
OR
GVHD most likely diagnosis but relevant clinical information is limited
OR
GVHD is validated by sequential biopsy or by absence of competing diagnosis
  • Abundant epithelial apoptosis without clinical or histological evidence of drug injury or infection

  • Evidence of CMV yet abundant apoptotic epithelial changes that are not associated with CMV infected cells by immunostaining

  • Single or rare apoptotic epithelial changes without other features of active GVHD and no alternative explanations

  • Limited sample or minimal or focal findings

  • Proximity to recent chemotherapy or radiotherapy

Included old categories of “Consistent with” and “Unequivocal” GVHD